Evidence map›Paper›PMID 29263215›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2018

Human NK Cells Downregulate Zap70 and Syk in Response to Prolonged Activation or DNA Damage.

Jason L Pugh, Neda Nemat-Gorgani, Paul J Norman, Lisbeth A Guethlein, Peter Parham

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. NK cells in HPV-related tumorigenesis: mechanisms and clinical applications.Frontiers in cellular and infection microbiology · 2025
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Chronic Ly49H Receptor EngagementFrontiers in immunology · 2019
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jason L PughDepartment of Structural Biology, Stanford University School of Medicine, Stanford, CA 94305; and.
Neda Nemat-GorganiDepartment of Structural Biology, Stanford University School of Medicine, Stanford, CA 94305; and.
Paul J NormanDepartment of Structural Biology, Stanford University School of Medicine, Stanford, CA 94305; and.ORCID 0000-0001-8370-7703
Lisbeth A GuethleinDepartment of Structural Biology, Stanford University School of Medicine, Stanford, CA 94305; and.ORCID 0000-0002-1301-8301
Peter ParhamDepartment of Structural Biology, Stanford University School of Medicine, Stanford, CA 94305; and peropa@stanford.edu.
Stanford University · US

Funding

Therapeutic Potential of Adaptive NK Cells in Cancer and TransplantationP01CA111412 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI MILLER, JEFFREY S. · 2005 to 2025
$38.2M
MOLECULAR &CELLULAR IMMUNOBIOLOGYT32AI007290 · NIAID · STANFORD UNIVERSITY · PI Sean Curtis Bendall, Olivia M Martinez · 1985 to 2026
$27.0M
INTERACTIONS BETWEEN HLA CLASS I &CYTOLYTIC LYMPHOCYTESR01AI022039 · NIAID · STANFORD UNIVERSITY · PI PARHAM, PETER R · 1985 to 2017
$5.2M
NCI NIH HHS P01 CA111412NIAID NIH HHS R01 AI022039
6 · The paper itself

Abstract

The extent of NK cell activity during the innate immune response affects downstream immune functions and, ultimately, the outcome of infectious or malignant disease. However, the mechanisms that terminate human NK cell responses have yet to be defined. When activation receptors expressed on NK cell surfaces bind to ligands on diseased cells, they initiate a signal that is propagated by a number of intracellular kinases, including Zap70 and Syk, eventually leading to NK cell activation. We assayed Zap70 and Syk content in NK cells from healthy human donors and identified a subset of NK cells with unusually low levels of these two kinases. We found that this Zap70

Indexed as

Cells, CulturedDNA DamageDown-RegulationHumansImmunity, InnateInterferon-gammaKiller Cells, NaturalLymphocyte ActivationNK Cell Lectin-Like Receptor Subfamily CReceptors, KIRSyk KinaseZAP-70 Protein-Tyrosine KinaseIFNG protein, humanInterferon-gammaNK Cell Lectin-Like Receptor Subfamily CReceptors, KIRSyk KinaseSYK protein, humanZAP70 protein, humanZAP-70 Protein-Tyrosine Kinase

Identifiers

PMID29263215
PMCPMC5780205
OpenAlexW2778976560

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.